Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A consumer network for haematological malignancies.
Skoetz N, Weingart O, Engert A. Skoetz N, et al. Among authors: engert a. Health Expect. 2005 Mar;8(1):86-90. doi: 10.1111/j.1369-7625.2004.00316.x. Health Expect. 2005. PMID: 15713174 Free PMC article. No abstract available.
Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T, Skoetz N, Trelle S, Bohlius J, Engert A; Cochrane Haematological Malignancies Group. Kober T, et al. Among authors: engert a. J Natl Cancer Inst. 2005 Aug 17;97(16):E2. doi: 10.1093/jnci/dji258. J Natl Cancer Inst. 2005. PMID: 16106014 Review. No abstract available.
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial.
Elter T, Borchmann P, Schulz H, Reiser M, Trelle S, Schnell R, Jensen M, Staib P, Schinköthe T, Stützer H, Rech J, Gramatzki M, Aulitzky W, Hasan I, Josting A, Hallek M, Engert A. Elter T, et al. Among authors: engert a. J Clin Oncol. 2005 Oct 1;23(28):7024-31. doi: 10.1200/JCO.2005.01.9950. Epub 2005 Sep 6. J Clin Oncol. 2005. PMID: 16145065 Clinical Trial.
596 results